Drug Trial Radar · NCT00671749
Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris
Last checked: Nov 20, 2026Latest source record: Aug 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Dec 2007
Primary completion
Aug 2008
Study completion Aug 2008
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- May 5, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to determine the efficacy and safety of 12 week treatment with Differin® Gel 0.3% applied in the evening, in combination with Duac® (Clindamycin/Benzoyl Peroxide Gel) applied in the morning, in Subjects with Acne vulgaris.
Conditions
- Acne Vulgaris
Interventions
adapalene gel, 0.3%Drug
Applied once daily at bedtime
clindamycin/benzoyl peroxide gelDrug
Applied once daily in the morning
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Total Lesion CountsTime frame: 6 and 12 weeks
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Center for Dermatology and Laser Surgery
Sacramento, California
Derm Research, P.L.L.C.
Louisville, Kentucky
Brodell Medical
Warren, Ohio
Northwest Cutaneous Research Specialists
Portland, Oregon
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.